within Pharmacolibrary.Drugs.ATC.A;

model A03AX03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 0.0002,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A03AX03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Chlorbenzoxamine is an anticholinergic and antihistaminic agent formerly used as an antispasmodic and to relieve smooth muscle spasms in the gastrointestinal tract. Its clinical use has been discontinued or is very limited in current practice and it is not approved in most modern formularies.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic data for chlorbenzoxamine in humans available in the scientific literature or pharmacokinetic databases.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A03AX03;
